HOME >> BIOLOGY >> NEWS
Factor identified that makes treating aging hearts with gene therapy difficult

Scientists at Massachusetts General Hospital (MGH) and their colleagues have found why older cardiac cells are more difficult to treat with gene therapy than younger cells. The findings, published in the May 4, 2003, issue of Circulation, have implications for therapeutic strategies aimed at the aging population.

"Efforts to develop gene therapy for heart disease have been geared towards the elderly since they have fewer therapeutic options," says principal investigator Roger Hajjar, MD, of the Cardiovascular Research Center at MGH. "Our results show that we have some hurdles to overcome in order to optimize treatments in this population."

The researchers found that gene transfer by adenovirus is less efficient in aging rat heart cells than in cells from their younger counterparts. Over the years, adenoviruses have been used in laboratory and clinical research to deliver beneficial genes into their target cells. These modified viruses rely on several proteins on the surface of cells in order to gain entry and deliver therapeutic genes.

Hajjar's group had previously shown that aging cells are more resistant to entry by adenovirus than adult cells, but it had not been clear why. Through detailed laboratory experiments, the research team found that crucial proteins called integrins, which sit just under a cell's membrane, are scarce in older cardiac cells. It turns out that adenoviruses need these integrins to get into cells.

"The adenovirus binds to a receptor on the outside of a cell that is linked to integrins below the cell's surface," says Hajjar, who is an associate professor of Medicine at Harvard Medical School. "The receptor itself is abundant in older cells, but the integrins are deficient."

This may sound like bad news for the elderly, but Hajjar points out that it is possible to boost the expression of integrins. "The next step is to devise different ways of stimulating integrins specifically so you can still u
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
3-Mar-2003


Page: 1 2

Related biology news :

1. Hemophilia therapy update: New information on investigational Factor VIII therapy development
2. Factor for acquiring skin barrier function identified
3. Enzyme Presence Could Be Key Factor In Wolf Health, Study Suggests
4. UCSF Scientists Report On A Transcription Factor That Could Stimulate Heart Cells To Repair Damage Caused By Heart Attacks Or Birth Defects
5. Genetic, Familial Factors Influence ADHD, Not Necessarily Sex Of Child
6. Allelix Clones Receptor For Intestinal Growth Factor GLP-2
7. Gene Influences Heart Disease And Stroke Risk Factors
8. Growth Factors Improve Muscle Healing In Animals
9. Growth Factor Contributes To Angiogenesis
10. One Way Traffic: Max Planck Scientists Idendified Genes Involved In Transporting An Important Plant Growth Factor
11. Environmental Factors Contribute To High Blood Pressure In African-American Males

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered ... common and aggressive adult brain cancer—announced today the appointments of its first Senior ... with supporting the organization’s initiatives and overall vision. , "Senior Fellows are more ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... development services, today announced that the company has received ISO9001:2015 certification for ... diagnostics, and research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s ...
(Date:6/23/2020)... ... 2020 , ... In its June 22 online post, business and technology news ... M.D., Ph.D., founder and director of stem cell biotechnology company Asymmetrex . Superb ... that starting July 5 it would begin offering free tissue stem cell counting ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... , ... The SDX® Respiratory Gating System , trusted ... its 20th anniversary of worldwide use. Introduced in the US over the past ... of Pennsylvania, University of Michigan, University of Maryland, University of California San Francisco—and ...
(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license ... to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 ...
(Date:7/7/2020)... (PRWEB) , ... July 06, 2020 , ... ... Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, ... 2003, Bio-IT World has hosted an elite awards program, highlighting outstanding examples of ...
Breaking Biology Technology:
Cached News: